Klebsiella species cause infections at multiple sites, including lung, urinary tract, bloodstream, wound or surgical site, and brain. These infections are more likely to occur in people with preexisting health conditions. Klebsiella pneumoniae (K. pneumoniae) has emerged as a major pathogen of international concern due to the increasing incidences of hypervirulent and carbapenem-resistant strains. It is imperative to understand risk factors, prevention strategies, and therapeutic avenues to treat multidrug-resistant Klebsiella infections. Here, we highlight the epidemiology, risk factors, and control strategies against K. pneumoniae infections to highlight the grave risk posed by this pathogen and currently available options to treat Klebsiella-associated diseases.
CITATION STYLE
Chang, D., Sharma, L., Dela Cruz, C. S., & Zhang, D. (2021, December 22). Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2021.750662
Mendeley helps you to discover research relevant for your work.